These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7252209)

  • 1. Cell-mediated immune alterations in uraemics before and after haemodialysis.
    Saha K; Gulati PD; Sharma RK; Rizvi SN
    J Indian Med Assoc; 1981 Feb; 76(3):36-41. PubMed ID: 7252209
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral and cell-mediated immunity in transfused uraemics.
    Dossetor JB; Kovithavongs T; Lao VS; Liburd EM; Lockwood JF; Schlaut J; Olson LA; Stiller CR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):455-63. PubMed ID: 4278129
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of cellular immunity in diabetic uraemics by cutaneous response to recall antigens and 2:4 dinitrochlorobenzene and T-cell rosette formation.
    Kuamr S; Singh RG; Gupta RM
    Indian J Pathol Microbiol; 1993 Apr; 36(2):129-32. PubMed ID: 8276475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell mediated immune reactivity in hemodialysis patients.
    Plavljanic D; Molnar V; Vitale B; Benkovic B
    Minerva Nefrol; 1979; 26(2):169-72. PubMed ID: 471343
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemodialysis and tuberculosis. Part two. Influence of haemodialysis on tuberculin reaction in uremic patients (author's transl)].
    Fujino T
    Kekkaku; 1976 Oct; 51(10):393-8. PubMed ID: 1011432
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of vitamin B6 on some immune responses in chronic uremia (author's transl)].
    Sorice F; De Simone C; Meli D; Ferrari M; Morellini M; De Luca D; Taccone Gallucci M; Casciani CU
    Acta Vitaminol Enzymol; 1980; 2(5-6):171-8. PubMed ID: 7293870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosette-inhibiting activity of uraemic sera and the influence of dialysis.
    Rowiński W; Lukasiewicz H; Orlowski T; Sluźewska W
    Proc Eur Dial Transplant Assoc; 1972; 9():507-13. PubMed ID: 4677520
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological parameters in uremic patients under hemodialysis].
    Pigareva NV; Polenova IM
    Klin Med (Mosk); 1981 Mar; 59(3):75-9. PubMed ID: 7265837
    [No Abstract]   [Full Text] [Related]  

  • 10. [Humoral and cellular immunity in uremia].
    Irkeç C; Irkeç M
    Mikrobiyol Bul; 1982 Jul; 16(3):191-5. PubMed ID: 7167069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic studies in uremia].
    Dall'Aglio P; Chizzolini C; Brigati C; Ghiringhelli P
    Minerva Nefrol; 1983; 30(2 Suppl):19-26. PubMed ID: 6602955
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of haemodialysis on cellular immunodeficiency in uraemic patients (author's transl)].
    Reis HE; Heimsoth VH; Hirche H; Eitelhuber U
    Klin Wochenschr; 1974 May; 52(9):437-43. PubMed ID: 4409847
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune system to uremia.
    Dobbelstein H
    Nephron; 1976; 17(6):409-14. PubMed ID: 13322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune potential in human uraemia. 2. Changes after regular haemodialysis therapy.
    Byron PR; Mallick NP; Taylor G
    J Clin Pathol; 1976 Sep; 29(9):770-2. PubMed ID: 789408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune dysfunction in uremia.
    Cohen G; Haag-Weber M; Hörl WH
    Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished chemokine and cytokine-induced adhesion of CD4+ T cells to extracellular matrix ligands in patients with end-stage renal failure.
    Zeltzer E; Bernheim J; Korzets Z; Zeeli D; Rathaus M; Mekori YA; Hershkoviz R
    Isr Med Assoc J; 2000 Apr; 2(4):282-6. PubMed ID: 10804903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the primary immune response in uremia and after extracorporeal irradiation of the blood.
    Weeke E; Bendixen G
    Acta Med Scand; 1972 Oct; 192(4):267-9. PubMed ID: 5081065
    [No Abstract]   [Full Text] [Related]  

  • 18. [The immune system in patients with uremia].
    Sułowicz W
    Przegl Lek; 1984; 41(12):723-8. PubMed ID: 6531456
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of zinc supplementation in chronic haemodialysis patients.
    Bonomini M; Di Paolo B; De Risio F; Niri L; Klinkmann H; Ivanovich P; Albertazzi A
    Nephrol Dial Transplant; 1993; 8(10):1166-8. PubMed ID: 8272232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.